Mkt Cap$2.23T-2.36%
24h Vol$63.67B
BTC Dom56.0%
ETH Dom9.6%
F&G28Fear
BTC$62,326.00-2.77% ETH$1,773.37-2.58% USDT$0.9991-0.03% BNB$566.41-2.52% USDC$0.9998+0.00% XRP$1.07-2.86% SOL$75.36-2.66% TRX$0.3257-1.56% FIGR_HELOC$1.01+0.00% HYPE$63.62-6.37% DOGE$0.0718-2.38% USDS$0.99970.00% RAIN$0.0145-0.35% LEO$9.53-0.29% ZEC$509.84-6.20% WBT$54.70-2.70% BTC$62,326.00-2.77% ETH$1,773.37-2.58% USDT$0.9991-0.03% BNB$566.41-2.52% USDC$0.9998+0.00% XRP$1.07-2.86% SOL$75.36-2.66% TRX$0.3257-1.56% FIGR_HELOC$1.01+0.00% HYPE$63.62-6.37% DOGE$0.0718-2.38% USDS$0.99970.00% RAIN$0.0145-0.35% LEO$9.53-0.29% ZEC$509.84-6.20% WBT$54.70-2.70%
News

Regulations

Total Stories
21
Section
Regulations
Why Did Outlook Therapeutics Shares Crash Today?
Market Analysis

Why Did Outlook Therapeutics (OTLK) Shares Crash Today?

Outlook Therapeutics stock crashed 70% in premarket after the FDA rejected its wet AMD drug application, citing insufficient efficacy evidence despite previous trial successes.

Tim FriesAug 28, 20253 min read